Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytarabine for Refractory Systemic Lupus Erythematosus
NCT00004643Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Feb 1995
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cytarabine in systemic lupus erythematosus (SLE), sponsored by National Center for Research Resources. Started Feb 1995; status: completed.
02
Drugs
cytarabine
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00004643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004643.